|
|
Volumn 94, Issue 16, 2002, Pages 1191-1193
|
|
FDA evaluating oxaliplatin for advanced colorectal cancer treatment
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
OXALIPLATIN;
ADVANCED CANCER;
CANCER GROWTH;
CANCER PATIENT;
CANCER SURVIVAL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG POTENTIATION;
DRUG SCREENING;
ESOPHAGUS CANCER;
FOOD AND DRUG ADMINISTRATION;
FRANCE;
HUMAN;
LICENSING;
MEDICAL SOCIETY;
NOTE;
OVARY CANCER;
PANCREAS CANCER;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
SIDE EFFECT;
TIME;
TREATMENT FAILURE;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 0037151389
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/94.16.1191 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|